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Objectives
. The purpose of this investigation was to determine
how often left ventricular function improves in recent onset
dilated cardiomyopathy of sufficient severity to cause referral for
heart transplantation and how to predict this improvement at the
time of evaluation for transplantation .
Background. Improvement has been reported to occur fre-
quently in patients with acute dilated cardioanyopathy but has not
been described specifically in these patients referred for tronsplan-
tation . To avoid potentially needless transplantation, it would be
useful to know the frequency of improvement and how to predict
it in these patients .
Methods. A consecutive series of 297 patients with primary
dilated cardiomyopathy evaluated for heart transplantation was
reviewed to identify those with onset of heart failure symptoms
within the preceding 6 months and to examine their outcome . The
clinical, echocardlographic, hemodynamic and laboratory profiles
of patients with improvement in left ventricular function (defined
as an increase in left ventricular ejection fraction ?0 .15 to a final
ejection fraction of ?O.30) were compared with those of patients
without improvement to assess which variables might p: edict
improvement .
In patients presenting with recent onset dilated cardiomyop-
athy, subsequent improvement in left ventricular function
has been reported in up to 37% (1) . However, the frequency
of improvement is not known for those with recent onset
cardiomyopathy of sufficient severity to require evaluation
for cardiac transplantation . Factors associated with im-
provement, which could be used to identify patients who are
likely to regain ventricular function and do well on medical
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. CIT 49 patients with recent onset dilated cardiomyop-
athy, 13 (27%) showed improvement, with an increase in mean
left ventricular ejection fraction from 0
.22 ± 0 .08 to 0 .49 ± 0 .09 .
All patients with improvement had survived without heart trans-
plantation at 43 ± 29 months
. Survival time was shorter in the
remaining 36 patients without improvement with recent onset
cardiomyopathy than in the 248 with chronic symptoms (p =
0.03)
and in younger compared with older patients with recent onset
cardlomyopathy (p = 0 .0001)
. By multivariate analysis, predic-
tors of improvement were shorter duration of symptoms, lower
pulmonary wedge and right atrial pressures and higher serum
sodium levels
.
Conclusions.
A minority of patients with dilated cardiomyop-
athy and symptoms for s6 months will have marked improvement
in left ventricular function, after which prognosis is excellent
despite previous referral for heart transplantation . Those with
symptom duration >3 months and more severe initial decompen-
sation as reflected by higher filling pressures and lower serum
sodium levels are unlikely to show improvement and may require
earlier consideration for heart transplantation
.
(J Am Coll Caediol 1994,23 .-553-9)
therapy, are also unknown . Avoiding cardiac transplantation
in these patients is important to spare them the risks of
rejection and immunosuppression and allow better allocation
of the limited number of donor hearts. Therefore, the rela-
tion among clinical characteristics, hemodynamic variables
and outcome were reviewed in patients with recent onset
dilated cardiomyopathy referred for transplantation . The
purpose of this investigation was to determine how often left
ventricular function improves and how to predict that im-
provement at the time of evaluation .
Methods
Study patients. The registry of all patients undergoing
complete evaluation for cardiac transplantation at the Uni-
versity of California, Los Angeles (UCLA) between January
1983 and June 1992 was reviewed to identify patients with
recent onset dilated cardiomyopathy . Dilated cardiomyopa-
thy was defined as a left ventricular ejection fraction :sO.45
in the absence of significant coronary artery disease or
0735-1097/94/$7 .00
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primary restrictive, hypertrophic, infiltrative, valvular or
chemotherapy-induced cardiomyopathy . Patients with ante-
cedent viral syndromes, peripartum cardiomyopathy, his-
tory of hypertension, diabetes or heavy alcohol use were
included because in an individual patient it is often unclear
whether these risk factors cause, exacerbate or have no
relation to the development of cardiomyopathy (2)
. Dilated
cardiomyopathy was defined as of recent onset if heart
failure symptoms were first noted within the 6 months before
evaluation. Patients with known cardiomegaly of >6
months' duration were not considered to have recent onset
cardiomyopathy regardless of symptom duration . The orig-
inal medical records of patients identified as having recent
onset cardiomyopathy were reviewed to confirm clinical
features, duration of symptoms, absence of excluding diag-
noses and endomyocardial biopsy results.
Initial evaluation . Evaluation for heart transplantation
included pulmonary artery catheterization with measure-
ment of cardiac output and ventricular filling pressures . Left
ventricular ejection fraction and dimensions were deter-
mined by two-dimensional echocardiography in all patients,
except two who had baseline and follow-up measurements of
ejection fraction by radionuclide angiography because echo-
cardiography was technically difficult . Neither of these pa-
tients had a significant change in ejection fraction over time .
Baseline clinical, echocardiographic, hemodynamic and lab-
oratory data were recorded at the time of transplant evalu-
ation. Endomyocardial biopsy procedures were obtained
either at UCLA or by the referring physicians in all patients
presenting with recent onset of symptoms, except those
believed to be at high risk for complications. The pathologic
specimens for biopsies performed elsewhere and reported as
positive for myocarditis were reviewed at UCLA and clas-
sified by the Dallas criteria (3)
.
Patients were treated with vasodilators tailored to hemo-
dynamic goals at the time of evaluation and were taught
management of low salt diets and self-adjustment of diuretic
drugs on the basis of daily weight . Patients had subsequent
follow-up at intervals of I week to 3 months, depending on
severity of illness and involvement of the referring physi-
cian. epeat echocardiograms were performed at intervals
of 6 to 12 months when possible .
Outcomes. Outcomes included death, cardiac transplan-
tation, survival without improvement and improvement
. All
patients were followed up for' 1 year or to death or cardiac
transplantation, except for one patient who showed im-
provement at 8 months and was then lost to follow-up
.
Patients who died or underwent transplantation before re-
peat echocardiography were considered to be without major
improvement
. In patients who survived without cardiac
transplantation, improvement was defined as an increase in
left ventricular ejection fraction X0
.15 to a final ejection
fraction >_0
.30.
Data analysis . Analysis included the clinical variables of
age, New York Heart Association functional class, symptom
duration before evaluation, the baseline echocardiographic
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variables of left ventricular ejection fraction, left ventricular
end-diastolic dimension and mitral regurgitation, the initial
hemodynamic variables of heart rate, cardiac output, mean
arterial and right atrial and pulmonary capillary wedge
pressures and serum sodium levels at presentation . Vari-
ables were evaluated for their association with the outcome
of improvement in recent onset cardiomyopathy by univari-
ate analysis. Variables with a p value < 0 .10 by univariate
analysis were entered into a stepwise logistic regression that
retained all independent variables with a p value < 0 .10 (4) .
The same variables were assessed for their association with
survival . Variables significant with a p value < 0 .10 by
univariate analysis were entered into a Cox proportional
hazards regression model that retained independent vari-
ables with a p value < 0 .10 (3) . The actuarial survival rate
was calculated using the Kaplan-Meier product limit esti-
mate with transplant candidates being censored at the time
of transplantation; survival between groups was compared
by the Mantel-Cox statistic. Proportions were compared
using the chi-square test . Group averages are expressed as
the mean value ± SD .
esults
During the period reviewed, 49 patients with recent onset
dilated cardiomyopathy were evaluated . Criteria for im-
provement were met in 13 (27%) of these, who had an
increase in left ventricular ejection fraction from 0 .22 t 0.08
to 0.49 ± 0 .09 (mean increase 0.27 ± 0 .08) . This increase in
ejection fraction was associated with a decrease in left
ventricular end-diastolic dimension from 67 ± 8 to 59
6 mm (p = 0 .0005) and in mitral regurgitation on a 0 to 3 scale
from 1 .3 ± 0.7 to 0 .6 ± 0.7 (p = 0.03). All patients with
improvement were alive at a follow-up interval of 43 ± 29
months (range 8 to 112) . Eight of these patients had serial
echocardiograms after their ejection fraction had increased
and none showed subsequent deterioration .
Of the 36 patients who did not meet criteria for improve-
ment, 18 died at a mean of 11 ± 14 months after evaluation
(nine sudden deaths, eight deaths attributed to hemodynamic
decompensation, one unspecified), 13 underwent cardiac
transplantation at 11 ± 16 months and 5 (14%) were alive
after 27 ± 22 (range 13 to 70) months of follow-up . Patients
with recent onset cardiomyopathy surviving 1 year without
improvement remained at risk for late deterioration ; of the
16 patients alive but without improvement at 1 year, 6 died,
3 underwent cardiac transplantation, 5 remained alive but
without improvement and 2 had subsequent improvement
(Fig. 1) . Among the patients who did not have documented
improvement, 12 of 31 patients who died or underwent
cardiac transplantation and all 5 who were alive at the end of
the follow-up period were followed up for a sufficient period
to have a repeat echocardiogram. The largest increase in left
ventricular ejection fraction in this unimproved group was
from 0.16 to 0
.27, whereas the mean change was only +0 .02
(Fig . 2)
. Change in left ventricular ejection fraction did not
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Figure 1. Outcome at I year and at the end of follow-up for 49
patients with recent onset dilated cardiomyopathy evaluated for
cardiac transplantation (Tx) . Of 16 patients alive without improve-
ment at I year, 9 patients died or underwent transplantation, 5
remained alive without improvement, and 2 had late improvement .
vary continuously . Those patients who had an increase in
ejection fraction tended to have a large increase, whereas
those who did not meet the study criteria for improvement
tended to have very little change ; therefore, the exact
definition of improvement did not greatly alter how patients
were classified .
In the majority of patients, the ejection fraction had
increased by the time of the second echocardiogram (8 ± 6
months) . However, in four patients with later improvement,
earlier echocardiograms at 5, 7 . 15 and 17 months showed
little increase in left ventricular ejection fraction, document-
ing that late improvement could occur .
The clinical and hemodynamic profiles of the 13 patients
with improvement and the 36 patients without improvement
in recent onset dilated cardiomyopathy are compared in
Table 1 . Both groups were young and had a similar fre-
quency of viral symptoms, history of heavy alcohol use,
peripartum onset, diabetes and hypertension . The initial left
ventricular ejection fraction did not differ significantly . Drug
Figure 2 . Initial and late ejection fraction (in %) in 30 patients with
recent onset cardiomyopathy . 13 of whom were defined as having
improvement (increase in left ventricular ejection fraction ? 15% to
a final ejection fraction ~tM) and 17 of whom had no improvement
and survived long enough without death or cardiac transplantation
to undergo repeat echocardiography . Improvement was generally
either minimal or dramatic . Solid lines represent patients defined as
improved ; dashed lines represent patients without improvement
.
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therapy during the follow-up period did not differ signifi-
cantly between the groups with and without improvement
;
patients in the two groups were treated with vasodilators,
nitrates, digoxin, diuretic drugs and type I antiarrhythmic
agents with similar frequency . Mitral regurgitation assessed
qualitatively by echocardiography tended to be less severe in
patients with improvement (p = 0
.06) . Myocarditis accord-
End of ing to the Dallas criteria (3) was diagnosed from only 3 (9%)
follow-up
of 35 endomyocardial biopsy specimens in both groups
combined .
By univariate analysis, improvement was significantly
associated with the presenting profile of shorter duration of
symptoms before evaluation, higher cardiac output, lower
functional class, smaller initial left ventricular end-diastolic
dimension, lower pulmonary capillary wedge and right atrial
pressures and higher serum sodium levels (Table 1) . By
stepwise logistic regression, short symptom duration before
evaluation was a strong independent predictor of improve-
meat. Three variables predicted improvement independently
of symptom duration : higher serum sodium level and lower
right atrial and pulmonary capillary wedge pressures . Nei-
ther cardiac output nor functional class was an independent
predictor. ight atrial and pulmonary capillary wedge pres-
sure were highly correlated (r = 0 .73) and were thus not
independent of one another . The relations among symptom
duration, wedge pressure and improvement is graphically
displayed in Figure 3 . Of the 13 patients with improvement,
10 had lower than mean values for both symptom duration
and pulmonary capillary wedge pressure ; both of these
variables were less than the mean in only 3 of 36 patients
without improvement .
Although shorter duration of symptoms was predictive of
improvement, it was not an independent predictor of sur-
vival. In contrast, lower pulmonary capillary wedge and
right atrial pressures and higher serum sodium levels pre-
dicted both improvement and survival by multivariate anal-
ysis . Older age was also independently predictive of survival
but was not associated with improvement. Patients with
recent onset cardiomyopathy who were younger than aver-
age (<33 years old) had only a 32% survival rate at 2 years
compared with a 90% rate for the older patients (p = Q000 I,
Fig. 4) . Differences in drug therapy did not appear to explain
the higher survival rate of older patients, who received heart
failure medications with a frequency similar to that of
younger patients : angiotensin-converting enzyme inhibitors
(61% vs. 46%, old vs
. young), hydralazine (35% vs . 35%),
nitrates (43% vs . 54%), digoxin (57% vs
. 38%), diuretic drugs
(100% vs
. 96%) and type I antiarrhythmic agents (22% vs .
23%) (p = NS for all five drugs) .
For purposes of comparison, the survival was examined
for the 248 of 297 patients who met the study criteria for
dilated cardiomyopathy but who had symptoms for >6
months
. The actuarial survival of these patients with chronic
cardiomyopathy and patients with recent onset did not differ
significantly at 3 years (49% vs
. 57%, Fig. 5) . Survival
remained similar when cardiac transplantation was equated
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Table 1
. Profiles of 49 Patients With ecent Onset Dilated Cardiomyopathy Evaluated for Heart
Transplantation
Figwte 3. Distribution of pulmonary capillary wedge pressures
(PCWP) and symptom durations before evaluation for heart trans-
plantation in 13 patients with recent onset cardiomyopathy who had
improvement and 36 who did not have improvement . The mean
wedge pressure (22 mm Hg) and symptom duration (2 .7 months) for
all 49 patients with recent onset cardiomyopathy are shown by
dashed lim .
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*Independently associated with improvement by multivariate analysis . Data are expressed as mean SD or
percent of patients. ACEI = angiotensin-converting enzyme inhibitor ; LVEDD = left ventricular end-diastolic
dimension ; LVEF = left ventricular ejection fraction : NYHA = New York Heart Association ; PCWP = pulmonary
capillary wedge pressure ; A = right atria] pressure .
with death as an end point . Survival was then considered compared with chronic cardiomyopathy, p = 0 .0075), and
separately for the patients with recent onset cardiomyopathy for those with recent onset cardiomyopathy without im-
who showed improvement, all of whom survived (survival provement, who had a lower survival at 3 years (34%) than
that of either the patients with improvement (p = 0.0009) or
the patients with chronic cardiomyopathy (p = 0 .03) .
Figure 4. Kaplan-Meier survival curves of patients with recent
onset cardiomyopathy who were younger (n = 26) and older (n = 23)
than the mean age (33 years) .
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Figure S . Kaplan-Meier survival curves of 297 patients with primary
dilated cardiomyopathy (CM) evaluated for cardiac transplantation .
Compared with the survival of patients with chronic cardiomyopa-
thy, the survival of all patients with recent onset cardio myopalby
was not significantly different, whereas the survival was significantly
worse for patients who had recent onset cardiomyopathy without
later improvement in left ventricular function (p = 0 .03) . Survival
for patients with recent onset cardiomyopathy and improvement
was better than either survival for patients without improvement
(p 0
.0009) or survival for patients with chronic cardiomyopathy
(p
0
.0075, all p values by Mantel-Cox statistic) . EF = left
ventricular ejection fraction .
Discussion
This study demonstrated that 13 (27%) of 49 patients with
recent onset dilated cardiomyopathy had a major improve-
ment in left ventricular function and that all patients with
improvement survived despite previous referral for cardiac
transplantation . Improvement in left ventricular function
was more common in patients with shorter symptom dura-
tion before evaluation and less severe clinical decompensa-
tion as reflected by hemodynamic values and serum sodium
levels. ecent onset cardiomyopathy in younger patients
and patients without early improvement was associated with
a poorer prognosis than that of chronic cardiomyopathy . The
present study is the first to specifically determine improve-
ment and outcome in patients referred for cardiac transplan-
tation with recent onset of cardiomyopathy symptoms .
Frequency of improvement . The potential for left ventric-
ular ejection fraction to improve in dilated cardiomyopathy
has been documented in the past (5-12). Most previous
reports (8-12) of improvement, however, have been for
cardiomyopathy selected for the presence of myocarditis on
biopsy rather than for short symptom duration . In these
reports, objective improvement in ventricular function has
varied in frequency (13,14) but has been noted in >50%
(10-12)
. Because myocarditis has been reported (1) to be
more common when heart failure symptoms are acute, the
likelihood of improvement in recent onset cardiomyopathy
might be expected to be similar to that seen in the presence
of myocarditis. However, in the present study, improvement
was seen in only 27% of patients with cardiomyopathy for
:56 months who were referred for cardiac transplantation .
STEIMLE ET AL .
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Only 9% of patients had myocarditis on biopsy diagnosed by
the Dallas criteria (3)
. This low rate of myocarditis is similar
to the rate observed in pooled series of unexplained cardio-
myopathy (13) and may have been due to delayed referral
.
Because patients whose condition improved rapidly may
never have been referred for cardiac transplantation, the
frequency of improvement observei,,'Id this study may be an
underestimate of the frequency of improvement in all recent
onset cardiomyopathy
. Nevertheless, these results indicate
that improvement occurs in a minority of patients with
recent onset cardiomyopathy evaluated for cardiac trans-
plantation and is less common than is suggested by reports of
cardiomyopathy associated with myocarditis
. Dec et al . (1)
also described improvement in dilated cardiomyopathy se-
lected for recent onset
. In 27 patients with unexplained
"acute dilated cardiomyopathy" who had symptoms for
:56
months, improvement was reported in 37% (mean increase
in ejection fraction from 0.21 to 0 .41)
. Using equivalent
ejection fraction criteria for improvement, the frequency
would have been 30%, similar to that in the present study
.
Although showing a similar rate of improvement, the pa-
tients studied by Dec et al
. (1) differed in that initial referral
was for endomyocardial biopsy rather than for cardiac
transplantation and myocarditis was diagnosed in a large
proportion (67%)
. In addition, the prognostic potential of the
hemodynamic profile was not explored
.
Survival. Although survival with recent onset and
chronic cardiomyopathy appeared to be similar, the recent
onset group represented a composite of two groups with
very different outcomes
. The patients with improvement all
survived and did not require subsequent cardiac transplan-
tation
. In contrast, patients with recent onset cardiomyopa-
thy who did not show improvement were actually less likely
to survive than were patients referred after 6 months of
symptoms (Fig . 5) . Survival without cardiac transplantation,
either with or without improvement, could be predicted in
patients with recent onset cardiomyopathy by lower cardiac
filling pressures (either right atrial or pulmonary capillary
wedge pressure), higher serum sodium levels and older age .
However, patients with recent onset cardiomyopathy who
were alive but without improvement at 1 year remained at
high risk for late deterioration ; >50% subsequently died or
underwent cardiac transplantation (Fig . 1) . To safely avoid
early cardiac transplantation that later might be unneces-
sary, it would be important to identify patients with recent
onset cardiomyopathy who are likely not only to survive the
1st year but also to have significant recovery of ventricular
function that allows long-term survival .
Predictors of improvement . By multivariate analysis, du-
ration of symptoms was a strong independent predictor of
improvement ; patients with symptoms for >3 months before
evaluation were unlikely to regain good ventricular function .
This finding suggests that recovery is rare after an extended
period of hemodynamic decompensation has caused severe
symptoms to persist without clinical improvement, such that
referral for cardiac transplantation is still required after 3
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months. Nevertheless, recovery of ventricular function
could occur late, and a few patients did not inci ease their
ejection fraction until > 1 year after referral . In contrast, Dec
et al. (1) found no association between symptom duration
and improvement and all patients who showed improvement
did so within the 1st 6 months . It is important to note that
duration of symptoms does not necessarily reflect the actual
time since the onset of cardiomyopathy . Asymptomatic
ventricular dilation may occur long before the onset of
symptoms in some patients, making it more difficult to detect
an association between symptom duration and improve-
ment. It is possible that the patients without improvement
had a longer period of asymptomatic ventricular dysfunction
and therefore their cardiomyopathy was considerably more
chronic than suggested by symptom duration . It is not clear
whether the results of Dec et al . (1) were related to a greater
disparity between overt symptom duration and actual dura-
tion of cardiomyopathy, the differing indication for referral,
the higher frequency of myocarditis or other intergroup
differences . Other investigators (6,7) have found an associ-
ation between improvement and shorter symptom duration
in patients with cardiomyopathy mixed with respect to
chronicity .
Either lower pulmonary capillary wedge or lower right
atrial pressure predicted improvement independently when
combined with symptom duration
. Patients were more likely
to show improvement if they had remained compensated
with low ventricular filling pressures at rest despite de-
pressed ejection fraction, indicating maintenance of more
normal diastolic function and systemic volume regulation for
a given degree of impairment in systolic function . One factor
in the compensation of patients with improvement was that
they had smaller mitral regurgitant volumes than those of
patients without improvement, allowing higher cardiac out-
puts despite similar ejection fractions and smaller ventricular
dimensions (Table 1) . Previously, lower ventricular filling
pressures have been correlated with survival in both recent
onset and chronic dilated cardiomyopathy (2,15-19), but this
study was the first to examine the relation between initial
hemodynamic status and subsequent improvement in ven-
tricular function
. A lower serum sodium level, which often
reflects increasing activation of the renin-angiotensin sys-
tem, was also an independent predictor of poor outcome, as
it has been in chronic heart failure (20)
. Other more direct
measures of neurohormonal activation, such as serum cate-
cholamine or plasma renin levels, were not routinely ob-
tained throughout the study period and could not be ana-
lyzed for their association with improvement or survival
.
Surprisingly, younger age did not predict improvement
and, in fact, was associated with a higher mortality rate (Fig
.
4)
. It is unclear whether the prognosis of younger patients
was poor because they had greater prevalence of certain
types of cardiac insults or because their immune, hemody-
namic and reflex responses to myocardial injury once it had
occurred led to more rapid progression
. The incidence of
previous heavy alcohol use, peripartum onset, diabetes and
JACC Vol . 23, No . 3
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hypertension did not differ between patients with and with-
out improvement but the number of patients was too small to
distinguish the possible effects of these risk factors on
outcome .
Limitations. This study was a retrospective analysis of a
relatively small number of improvement outcomes and was
limited in the number of variables it could accurately screen
for predictive value . Therefore, it will be important to
validate these suggested predictors prospectively
. It is pos-
sible that some of the patients without improvement had
unappreciated improvement in ventricular function initially
and deterioration later . The fact that gone of the eight
patients with improvement who had serial echocardiograms
after their ejection fraction had increased showed subse-
quent deterioration argues that this was not common . This
study was not designed to determine the rate of improve-
ment in patients with chronic cardiomyopathy, in whom
serial echocardiograms were not routinely obtained
. Nor
was the study designed to examine the influence of drugs on
improvement
. Although there were no significant differences
in the use of vasodilators or other agents that could explain
greater survival in patients with improvement or in older
patients, the study groups were too small to reliably identify
the possible effects of these therapies on survival and
improvement .
Implications . Patients with dilated cardiomyopathy for
56 months can have marked improvement in left ventricular
function even after referral for cardiac transplantation and it
is reasonable to defer transplantation for some of these
patients
. The frequency of improvement, however, may be
lower than previously reported for other groups of patients
with recent onset cardiomyopathy . Patients with longer
duration of symptoms or more severe initial decompensa-
tion, as reflected by higher ventricular filling pressures and
lower serum sodium levels, may stabilize symptomatically
but are unlikely to regain good ventricular function
. Because
these patients, particularly if younger, remain at risk for
deterioration and may have a worse prognosis than that of
patients with longer-term symptoms, they should be fol-
lowed up closely and may require earlier consideration for
cardiac transplantation .
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